February 21, 2018 / 4:18 PM / 3 months ago

BRIEF-Genmab ‍2017 Operating Profit Beats Expectations

Feb 21 (Reuters) - GENMAB:

* ‍OPERATING INCOME WAS DKK 1,344 MLN IN 2017​

* SEES 2018 REVENUE AT DKK ‍2,700 - 3,100​ MLN

* SEES 2018 OPERATING EXPENSES AT DKK 1,400-1,600 MLN​

* SEES 2018 ‍OPERATING INCOME AT DKK 1,300-1,500​ MLN

* ‍PROJECTED REVENUE FOR 2018 CONSISTS PRIMARILY OF DARZALEX ROYALTIES OF APPROXIMATELY DKK 1,750 MLN THAT ARE BASED ON AN ESTIMATED USD 2.0 - 2.3 BLN OF DARZALEX NET SALES IN 2018​

* ‍PROJECTS DARZALEX MILESTONES OF APPROXIMATELY DKK 550 MLN IN 2018​

* ‍2018 GUIDANCE INCLUDES ONE-TIME PAYMENT FROM NOVARTIS OF APPROXIMATELY DKK 300 MLN​​ SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Reporting by Jacob Gronholt-Pedersen)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below